Adial Pharmaceuticals Inc...
(ADIL) ✕
AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
undefined
undefined%
At close: undefined
1.04
-4.58%
After-hours Jan 07, 2025, 05:09 PM EST
Income Statement (Annual)
Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 |
Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | 564.00 | 60.50K | 55.11K | 564.00 | 565.00 | 563.00 | 565.00 | 565.00 | 565.00 |
Gross Profit | -564 | -60.50K | -55.11K | -564 | -565 | -563 | -565 | -565 | -565 |
Operating Income | -6.89M | -13.32M | -19.29M | -10.93M | -8.24M | -6.99M | -995.29K | -410.81K | -819.26K |
Interest Income | 69.78K | 63.34K | 6.54K | 32.49K | 95.23K | 7.39K | 367.00 | 240.00 | 1.26K |
Pretax Income | -7.00M | -12.73M | -19.52M | -10.89M | -8.59M | -11.63M | -1.14M | -420.20K | -817.99K |
Net Income | -7.00M | -12.73M | -19.42M | -10.86M | -8.59M | -11.63M | -1.14M | -420.20K | -817.99K |
Selling & General & Admin | 5.62M | 9.14M | 9.34M | 5.07M | 4.28M | 6.62M | 813.18K | 264.66K | 497.15K |
Research & Development | 1.27M | 4.18M | 8.40M | 5.85M | 3.97M | 368.46K | 182.11K | 146.14K | 322.11K |
Other Expenses | n/a | n/a | 46.49K | 2.50K | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 6.89M | 13.32M | 17.74M | 10.93M | 8.24M | 6.99M | 995.29K | 410.81K | 819.26K |
Interest Expense | n/a | n/a | n/a | n/a | n/a | 1.17M | 144.54K | 9.64K | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 6.89M | 13.32M | 17.74M | 10.93M | 8.24M | 6.99M | 995.29K | 410.81K | 819.26K |
Income Tax | n/a | -502 | -94.08K | -32.49K | -76.06K | -3.48M | 367.00 | 9.64K | 1.26K |
Shares Outstanding (Basic) | 1.42M | 1.06M | 743.55K | 498.52K | 394.10K | 190.37K | 218.99K | 191.13K | 191.28K |
Shares Outstanding (Diluted) | 1.42M | 1.06M | 743.55K | 498.52K | 394.10K | 190.37K | 218.99K | 191.13K | 191.28K |
EPS (Basic) | -5.44 | -11.98 | -26.12 | -21.79 | -21.8 | -61.1 | -5.2 | -2.2 | -4.28 |
EPS (Diluted) | -5.44 | -11.98 | -26.12 | -21.79 | -21.8 | -61.1 | -5.2 | -2.2 | -4.28 |
EBITDA | -7.00M | -13.32M | -19.46M | -10.93M | -8.15M | -6.98M | -994.35K | -410.00K | -817.43K |
Depreciation & Amortization | 564.00 | 564.00 | 55.11K | 564.00 | 565.00 | 563.00 | 565.00 | 565.00 | 565.00 |